TrialVaccine2010

Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon.

Benjamin Mordmüller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.